碳青霉烯
药效学
药代动力学
抗生素
药理学
医学
广谱
抗菌管理
抗菌剂
重症监护医学
头孢菌素
化学
生物
微生物学
抗生素耐药性
组合化学
作者
Sena Sayood,Elizabeth Neuner,Rebekah E. Dumm,Sumanth Gandra
摘要
SUMMARY The penem and carbapenem antibiotics provide some of the broadest spectrum coverage available and generally should only be used when narrower options are unavailable. The majority of available carbapenems can only be administered parenterally, but two orally administered penems (faropenem and sulopenem) and one orally administered carbapenem (tebipenem) are in increased use due to approvals in new markets. These oral agents have a spectrum of activity similar to widely used parenteral carbapenems but are simpler to administer than intravenous agents and will likely experience rapid increases in their rates of use as they are approved in new markets. In this review, we discuss their spectra of activity, pharmacokinetics, pharmacodynamics, clinical efficacy, toxicity, antimicrobial stewardship considerations, and potential clinical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI